1. Home
  2. FSBC vs CRGX Comparison

FSBC vs CRGX Comparison

Compare FSBC & CRGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FSBC
  • CRGX
  • Stock Information
  • Founded
  • FSBC 2002
  • CRGX 2021
  • Country
  • FSBC United States
  • CRGX United States
  • Employees
  • FSBC N/A
  • CRGX N/A
  • Industry
  • FSBC Banks
  • CRGX
  • Sector
  • FSBC Finance
  • CRGX
  • Exchange
  • FSBC Nasdaq
  • CRGX Nasdaq
  • Market Cap
  • FSBC 565.6M
  • CRGX 190.0M
  • IPO Year
  • FSBC 2021
  • CRGX 2023
  • Fundamental
  • Price
  • FSBC $28.66
  • CRGX $4.16
  • Analyst Decision
  • FSBC Buy
  • CRGX Hold
  • Analyst Count
  • FSBC 4
  • CRGX 7
  • Target Price
  • FSBC $34.75
  • CRGX $4.67
  • AVG Volume (30 Days)
  • FSBC 57.1K
  • CRGX 586.4K
  • Earning Date
  • FSBC 07-23-2025
  • CRGX 08-11-2025
  • Dividend Yield
  • FSBC 2.81%
  • CRGX N/A
  • EPS Growth
  • FSBC N/A
  • CRGX N/A
  • EPS
  • FSBC 2.27
  • CRGX N/A
  • Revenue
  • FSBC $124,973,000.00
  • CRGX N/A
  • Revenue This Year
  • FSBC $25.86
  • CRGX $57.81
  • Revenue Next Year
  • FSBC $15.15
  • CRGX N/A
  • P/E Ratio
  • FSBC $12.56
  • CRGX N/A
  • Revenue Growth
  • FSBC 11.14
  • CRGX N/A
  • 52 Week Low
  • FSBC $22.22
  • CRGX $3.00
  • 52 Week High
  • FSBC $35.13
  • CRGX $25.45
  • Technical
  • Relative Strength Index (RSI)
  • FSBC 57.94
  • CRGX 45.07
  • Support Level
  • FSBC $27.47
  • CRGX $4.33
  • Resistance Level
  • FSBC $28.27
  • CRGX $4.36
  • Average True Range (ATR)
  • FSBC 0.72
  • CRGX 0.19
  • MACD
  • FSBC 0.13
  • CRGX -0.04
  • Stochastic Oscillator
  • FSBC 79.86
  • CRGX 21.76

About FSBC Five Star Bancorp

Five Star Bancorp is a bank holding company through its subsidiary it operates in California state-chartered non-member bank. The Company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment; Banking.

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.

Share on Social Networks: